These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32798611)

  • 21. Reliability of the AR-CALUX®In Vitro Method Used to Detect Chemicals with (Anti)Androgen Activity: Results of an International Ring Trial.
    Milcamps A; Liska R; Langezaal I; Casey W; Dent M; Odum J
    Toxicol Sci; 2021 Oct; 184(1):170-182. PubMed ID: 34165557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
    Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
    Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine Learning Consensus To Predict the Binding to the Androgen Receptor within the CoMPARA Project.
    Grisoni F; Consonni V; Ballabio D
    J Chem Inf Model; 2019 May; 59(5):1839-1848. PubMed ID: 30668916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay.
    Shaw J; Leveridge M; Norling C; Karén J; Molina DM; O'Neill D; Dowling JE; Davey P; Cowan S; Dabrowski M; Main M; Gianni D
    Sci Rep; 2018 Jan; 8(1):163. PubMed ID: 29317749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of androgen receptor agonistic/antagonistic effects on 25 chemicals in household applicants by OECD in vitro stably transfected transcriptional activation assays.
    Lee HS; Park EJ; Han S; Oh GY; Kang HS; Suh JH; Shin MK; Oh HS; Hwang MS; Moon G; Koh YH; Park Y; Hong JH; Koo YE
    Chemosphere; 2018 Jan; 191():589-596. PubMed ID: 29073568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multifunctional androgen receptor screening assay using the high-throughput Hypercyt flow cytometry system.
    Dennis MK; Bowles HJ; MacKenzie DA; Burchiel SW; Edwards BS; Sklar LA; Prossnitz ER; Thompson TA
    Cytometry A; 2008 May; 73(5):390-9. PubMed ID: 18340645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays.
    Zhou W; Duan M; Fu W; Pang J; Tang Q; Sun H; Xu L; Chang S; Li D; Hou T
    Genomics Proteomics Bioinformatics; 2018 Dec; 16(6):416-427. PubMed ID: 30639122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of activity cliffs in structure-activity landscape of androgen receptor binding chemicals.
    Vivek-Ananth RP; Sahoo AK; Baskaran SP; Ravichandran J; Samal A
    Sci Total Environ; 2023 May; 873():162263. PubMed ID: 36801331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Workflow for defining reference chemicals for assessing performance of in vitro assays.
    Judson RS; Thomas RS; Baker N; Simha A; Howey XM; Marable C; Kleinstreuer NC; Houck KA
    ALTEX; 2019; 36(2):261-276. PubMed ID: 30570668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells.
    Johnston PA; Nguyen MM; Dar JA; Ai J; Wang Y; Masoodi KZ; Shun T; Shinde S; Camarco DP; Hua Y; Huryn DM; Wilson GM; Lazo JS; Nelson JB; Wipf P; Wang Z
    Assay Drug Dev Technol; 2016 May; 14(4):226-39. PubMed ID: 27187604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high throughput screening system for predicting chemically-induced reproductive organ deformities.
    van der Burg B; Pieterse B; Buist H; Lewin G; van der Linden SC; Man HY; Rorije E; Piersma AH; Mangelsdorf I; Wolterbeek AP; Kroese ED; van Vugt-Lussenburg B
    Reprod Toxicol; 2015 Aug; 55():95-103. PubMed ID: 25527862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation and validation of an in vitro transactivation assay based on the 22Rv1/MMTV_GR-KO cell line to detect human androgen receptor agonists and antagonists.
    Park Y; Jung DW; Milcamps A; Takeyoshi M; Jacobs MN; Houck KA; Ono A; Bovee TFH; Browne P; Delrue N; Kang Y; Lee HS
    Food Chem Toxicol; 2021 Jun; 152():112206. PubMed ID: 33887398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-Cell Distribution Analysis of AR Levels by High-Throughput Microscopy in Cell Models: Application for Testing Endocrine-Disrupting Chemicals.
    Stossi F; Mistry RM; Singh PK; Johnson HL; Mancini MG; Szafran AT; Mancini MA
    SLAS Discov; 2020 Aug; 25(7):684-694. PubMed ID: 32552291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus.
    Sakkiah S; Wang T; Zou W; Wang Y; Pan B; Tong W; Hong H
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor in human health: a potential therapeutic target.
    Siddique HR; Nanda S; Parray A; Saleem M
    Curr Drug Targets; 2012 Dec; 13(14):1907-16. PubMed ID: 23140299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding.
    Zhu Z; Shi M; Hu W; Estrella H; Engebretsen J; Nichols T; Briere D; Hosea N; Los G; Rejto PA; Fanjul A
    BMC Genomics; 2012 Jul; 13():355. PubMed ID: 22849360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental (anti-)androgenic chemicals affect germinal vesicle breakdown (GVBD) of Xenopus laevis oocytes in vitro.
    Cao S; Xu W; Lou QQ; Zhang YF; Zhao YX; Wei WJ; Qin ZF
    Toxicol In Vitro; 2014 Apr; 28(3):426-31. PubMed ID: 24362045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells.
    Auvin S; Öztürk H; Abaci YT; Mautino G; Meyer-Losic F; Jollivet F; Bashir T; de Thé H; Sahin U
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31431473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays.
    Kolle SN; Kamp HG; Huener HA; Knickel J; Verlohner A; Woitkowiak C; Landsiedel R; van Ravenzwaay B
    Toxicol In Vitro; 2010 Oct; 24(7):2030-40. PubMed ID: 20732407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
    Hua Y; Shun TY; Strock CJ; Johnston PA
    Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.